A5022031181- Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia research
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Protein Degradation and Inhibitors
- Advanced Biosensing Techniques and Applications
- Testicular diseases and treatments
- CAR-T cell therapy research
- Renal Transplantation Outcomes and Treatments
- Blood disorders and treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Telemedicine and Telehealth Implementation
- Childhood Cancer Survivors' Quality of Life
- Chronic Myeloid Leukemia Treatments
- Genital Health and Disease
- Organ Transplantation Techniques and Outcomes
- Viral-associated cancers and disorders
- Organizational Strategy and Culture
- Immune Cell Function and Interaction
- CNS Lymphoma Diagnosis and Treatment
- Urologic and reproductive health conditions
- Leadership and Management in Organizations
- Healthcare Quality and Management
Cancer Treatment Centers of America
2022
Arizona Oncology
2019
HonorHealth
2016-2018
City of Hope
2005-2008
City Of Hope National Medical Center
2002-2007
Banner Health
2007
Toronto Western Hospital
1990
Over the past decade, therapeutic options in multiple myeloma (MM) have changed dramatically. Given unprecedented efficacy of novel agents, role hematopoietic cell transplantation (HCT) MM remains under scrutiny. Rapid advances immunotherapy including recent approval chimeric antigen receptor (CAR) T-cell therapy will impact landscape. The American Society for Transplantation and Cellular Therapy convened an expert panel to formulate clinical practice recommendations role, timing, sequencing...
Significant advances in hematopoietic cell transplantation (HCT) have increased the long-term survivorship of its recipients, but because unique complications arising from radiation and chemotherapy, recipients require lifelong follow-up. To evaluate current or follow-up (LTFU) clinics specifically for HCT survivors to potential barriers their establishment, American Society Blood Marrow Transplantation (ASBMT) Practice Guidelines Committee electronically surveyed 200 programs gather...
Although autologous stem cell transplantation (ASCT) for patients with relapsed/refractory Hodgkin lymphoma (HL) appears to offer a survival advantage over conventional therapy, only approximately 25% 35% of primary progressive or poor-risk recurrent HL can achieve durable remission after ASCT, disease transplant accounting most the treatment failures. We conducted pilot study evaluate toxicities and efficacy tandem approach in this subgroup patients. Between April 1998 March 2000, 46 were...
Combination therapy with a calcineurin inhibitor (CNI), such as cyclosporine (CSA) or tacrolimus (Tac), and methotrexate (MTX) mycophenolate mofetil (MMF) is widely used approach to graft-versus-host disease (GVHD) prevention. Data on the comparative effectiveness of MMF compared MTX are limited conflicting, however. We analyzed data from Center for International Blood Marrow Transplant Research adult patients undergoing first myeloablative hematopoietic cell transplantation (HCT) an...
Allogeneic HCT (Allo-HCT) is an effective treatment option for CLL due to both cytoreductive therapy from the conditioning regimen as well graft versus leukemia (GVL) effect. Traditionally, chemosensitivity a pre-requisite Allo-HCT; however, this may not be necessary in GVL We identified consecutive case-series of 29 patients who underwent Allo-HCT at City Hope Medical Center between1993 and 2006. The median age transplantation was 48 years (38–68). time diagnosis transplant 49 months...
Continuous quality improvement is critical for organizations as they strive to provide performance excellence. The Baldrige award used recognize role model behaviors the highest achievement in United States business and service Health care currently comprises over half of all applicants. approach unique that it not prescriptive, rather provides a framework description what applicant does, how perform this well compare others providing similar services. Although few win, applying forces...